Senolytics Plus Immunotherapy Shows Promise Against Head and Neck Cancer
Phase 2 trial combining senescent cell-clearing drugs with anti-PD-1 therapy achieved 33% response rate in head and neck cancer patients.
Biological age reversal, epigenetic clocks, senolytics, and anti-aging interventions
621 articles
Phase 2 trial combining senescent cell-clearing drugs with anti-PD-1 therapy achieved 33% response rate in head and neck cancer patients.
Study of 3,566 adults finds healthy sleep habits reduce epigenetic aging markers, with strongest effects in older participants.
Analysis of 6,200 adults reveals exercise preserves telomeres and reduces biological age, offering new insights into healthy aging mechanisms.
Study of 6,681 adults reveals phenotypic age captures thyroid dysfunction risk more accurately than calendar age alone.
Large UK study reveals EAT-Lancet diet outperforms traditional plant-based diets in slowing biological aging through metabolomic pathways.
New research reveals how physical activity reduces biological aging markers through β2-microglobulin, offering molecular insights into exercise benefits.
New research explores how PhenoAge, a biological aging measure, correlates with Alzheimer's biomarkers and cognitive function.
Large study reveals how tooth loss accelerates biological aging through poor diet quality, increasing mortality risk by 28%.
Large US study finds consuming live microbes in food linked to younger biological age, potentially through improved insulin function.
Large UK study reveals accelerated biological aging raises stroke risk by 28%, with genetic factors amplifying the effect significantly.
Large NHANES study reveals accelerated biological aging increases mortality risk in RA patients by up to 7.5% per year of acceleration.
New research reveals how body roundness measurements may predict accelerated aging at the cellular level.